Several studies indicated that BBB disruption is a modus operandi for metastasizing cells from triple-negative breast cancer (TNBC) and basal-type breast cancers but not those from HER2/neu-positive breast cancer [50, 51], but the reason for this difference is currently unknown. The gene discussed is ERBB2; the disease is breast carcinoma.